108 related articles for article (PubMed ID: 12820423)
1. Matrix-metalloproteinases in Hodgkin lymphoma.
Thorns C; Bernd HW; Hatton D; Merz H; Feller AC; Lange K
Anticancer Res; 2003; 23(2B):1555-8. PubMed ID: 12820423
[TBL] [Abstract][Full Text] [Related]
2. Emmprin, a cell surface inducer of matrix metalloproteinases (MMPs), is expressed in T-cell lymphomas.
Nabeshima K; Suzumiya J; Nagano M; Ohshima K; Toole BP; Tamura K; Iwasaki H; Kikuchi M
J Pathol; 2004 Mar; 202(3):341-51. PubMed ID: 14991900
[TBL] [Abstract][Full Text] [Related]
3. Differential expression of matrilysin-1 (MMP-7), 92 kD gelatinase (MMP-9), and metalloelastase (MMP-12) in oral verrucous and squamous cell cancer.
Impola U; Uitto VJ; Hietanen J; Hakkinen L; Zhang L; Larjava H; Isaka K; Saarialho-Kere U
J Pathol; 2004 Jan; 202(1):14-22. PubMed ID: 14694517
[TBL] [Abstract][Full Text] [Related]
4. Immunohistochemical expression of angiogenic cytokines in childhood Hodgkin lymphoma.
Citak EC; Oguz A; Karadeniz C; Akyurek N
Pathol Res Pract; 2008; 204(2):89-96. PubMed ID: 18207652
[TBL] [Abstract][Full Text] [Related]
5. Calcifying Cystic Odontogenic Tumour: immunohistochemical expression of matrix metalloproteinases, their inhibitors (TIMPs and RECK) and inducer (EMMPRIN).
Prosdócimi FC; Rodini CO; Sogayar MC; Sousa SC; Xavier FC; Paiva KB
J Oral Pathol Med; 2014 Aug; 43(7):545-53. PubMed ID: 24484176
[TBL] [Abstract][Full Text] [Related]
6. Tumor-stroma interaction: positive feedback regulation of extracellular matrix metalloproteinase inducer (EMMPRIN) expression and matrix metalloproteinase-dependent generation of soluble EMMPRIN.
Tang Y; Kesavan P; Nakada MT; Yan L
Mol Cancer Res; 2004 Feb; 2(2):73-80. PubMed ID: 14985463
[TBL] [Abstract][Full Text] [Related]
7. Downregulation of vascular matrix metalloproteinase inducer and activator proteins in hypertensive patients.
Ergul A; Portik-Dobos V; Hutchinson J; Franco J; Anstadt MP
Am J Hypertens; 2004 Sep; 17(9):775-82. PubMed ID: 15363819
[TBL] [Abstract][Full Text] [Related]
8. Immunocytochemical detection of MMP-3 and -10 expression in hepatocellular carcinomas.
Bodey B; Bodey B; Siegel SE; Kaiser HE
Anticancer Res; 2000; 20(6B):4585-90. PubMed ID: 11210857
[TBL] [Abstract][Full Text] [Related]
9. Expression of matrix metalloproteinases in benign and malignant follicular thyroid lesions.
Cho Mar K; Eimoto T; Tateyama H; Arai Y; Fujiyoshi Y; Hamaguchi M
Histopathology; 2006 Feb; 48(3):286-94. PubMed ID: 16430475
[TBL] [Abstract][Full Text] [Related]
10. Increased expression of extracellular matrix metalloproteinase inducer is associated with matrix metalloproteinase-1 and -2 in gingival tissues from patients with periodontitis.
Dong W; Xiang J; Li C; Cao Z; Huang Z
J Periodontal Res; 2009 Feb; 44(1):125-32. PubMed ID: 19515022
[TBL] [Abstract][Full Text] [Related]
11. Extracellular matrix metalloproteinase inducer regulates matrix metalloproteinase activity in cardiovascular cells: implications in acute myocardial infarction.
Schmidt R; Bültmann A; Ungerer M; Joghetaei N; Bülbül O; Thieme S; Chavakis T; Toole BP; Gawaz M; Schömig A; May AE
Circulation; 2006 Feb; 113(6):834-41. PubMed ID: 16461815
[TBL] [Abstract][Full Text] [Related]
12. Invasion and metastasis: the expression and significance of matrix metalloproteinases in carcinomas of the lung.
Bodey B; Bodey B; Gröger AM; Siegel SE; Kaiser HE
In Vivo; 2001; 15(2):175-80. PubMed ID: 11317524
[TBL] [Abstract][Full Text] [Related]
13. Expression of CD147 on monocytes/macrophages in rheumatoid arthritis: its potential role in monocyte accumulation and matrix metalloproteinase production.
Zhu P; Ding J; Zhou J; Dong WJ; Fan CM; Chen ZN
Arthritis Res Ther; 2005; 7(5):R1023-33. PubMed ID: 16207318
[TBL] [Abstract][Full Text] [Related]
14. Evidence of abortive plasma cell differentiation in Hodgkin and Reed-Sternberg cells of classical Hodgkin lymphoma.
Buettner M; Greiner A; Avramidou A; Jäck HM; Niedobitek G
Hematol Oncol; 2005; 23(3-4):127-32. PubMed ID: 16342298
[TBL] [Abstract][Full Text] [Related]
15. Stromal cells as the major source for matrix metalloproteinase-2 in cutaneous melanoma.
Hofmann UB; Eggert AA; Blass K; Bröcker EB; Becker JC
Arch Dermatol Res; 2005 Oct; 297(4):154-60. PubMed ID: 16047212
[TBL] [Abstract][Full Text] [Related]
16. Immunohistochemical detection of MT1-MMP, RECK, and EMMPRIN in ameloblastic tumors.
Kumamoto H; Ooya K
J Oral Pathol Med; 2006 Jul; 35(6):345-51. PubMed ID: 16762015
[TBL] [Abstract][Full Text] [Related]
17. Expression of matrix metalloproteinase (MMP)-7 and MMP-13 and loss of MMP-19 and p16 are associated with malignant progression in chronic wounds.
Impola U; Jeskanen L; Ravanti L; Syrjänen S; Baldursson B; Kähäri VM; Saarialho-Kere U
Br J Dermatol; 2005 Apr; 152(4):720-6. PubMed ID: 15840104
[TBL] [Abstract][Full Text] [Related]
18. EMMPRIN (CD 147) is a central activator of extracellular matrix degradation by Chlamydia pneumoniae-infected monocytes. Implications for plaque rupture.
Schmidt R; Redecke V; Breitfeld Y; Wantia N; Miethke T; Massberg S; Fischel S; Neumann FJ; Schömig A; May AE
Thromb Haemost; 2006 Jan; 95(1):151-8. PubMed ID: 16543974
[TBL] [Abstract][Full Text] [Related]
19. Expression of extracellular matrix metalloproteinase inducer and matrix metalloproteinases during mouse embryonic development.
Chen L; Nakai M; Belton RJ; Nowak RA
Reproduction; 2007 Feb; 133(2):405-14. PubMed ID: 17307908
[TBL] [Abstract][Full Text] [Related]
20. Expression of matrix metalloproteinase-9 (MMP-9) and tissue inhibitor of matrix metalloproteinase (TIMP-1) in tissues with a diagnosis of childhood lymphoma.
Bozkurt C; Ertem U; Oksal A; Sahin G; Yüksek N; Birgen D
Pediatr Hematol Oncol; 2008 Sep; 25(7):621-9. PubMed ID: 18850474
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
